These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 2874783)

  • 1. Additive effect of betaxolol and epinephrine in primary open angle glaucoma.
    Allen RC; Epstein DL
    Arch Ophthalmol; 1986 Aug; 104(8):1178-84. PubMed ID: 2874783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A double-masked randomized comparison of the efficacy and safety of unoprostone with timolol and betaxolol in patients with primary open-angle glaucoma including pseudoexfoliation glaucoma or ocular hypertension. 6 month data.
    Nordmann JP; Mertz B; Yannoulis NC; Schwenninger C; Kapik B; Shams N;
    Am J Ophthalmol; 2002 Jan; 133(1):1-10. PubMed ID: 11755834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of betaxolol and timolol in open angle glaucoma and ocular hypertension.
    Feghali JG; Kaufman PL; Radius RL; Mandell AI
    Acta Ophthalmol (Copenh); 1988 Apr; 66(2):180-6. PubMed ID: 2898859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the efficacy of betaxolol and timolol in ocular hypertension with or without adrenaline.
    Clark JB; Brooks AM; Harper CA; Mantzioros N; Gillies WE
    Aust N Z J Ophthalmol; 1989 May; 17(2):173-7. PubMed ID: 2569321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A double-masked comparison of betaxolol vs timolol in the treatment of open-angle glaucoma.
    Allen RC; Hertzmark E; Walker AM; Epstein DL
    Am J Ophthalmol; 1986 May; 101(5):535-41. PubMed ID: 3518464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of the additive effect of timolol and epinephrine in lowering intraocular pressure.
    Thomas JV; Epstein DL
    Br J Ophthalmol; 1981 Sep; 65(9):596-602. PubMed ID: 7028085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Betaxolol and timolol. A comparison of efficacy and side effects.
    Berry DP; Van Buskirk EM; Shields MB
    Arch Ophthalmol; 1984 Jan; 102(1):42-5. PubMed ID: 6367723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Timolol and epinephrine in primary open angle glaucoma. Transient additive effect.
    Thomas JV; Epstein DL
    Arch Ophthalmol; 1981 Jan; 99(1):91-5. PubMed ID: 7006581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of adding betaxolol to dipivefrin therapy.
    Weinreb RN; Ritch R; Kushner FH
    Am J Ophthalmol; 1986 Feb; 101(2):196-8. PubMed ID: 3946535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparative study between timolol and d-epinephrine in the treatment of open-angle glaucoma (author's transl)].
    Merkle W
    Klin Monbl Augenheilkd; 1981 Mar; 178(3):203-5. PubMed ID: 7014999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The favorable effect of topical betaxolol and timolol on glaucomatous visual fields: a 2-year follow-up study.
    Vainio-Jylhä E; Vuori ML
    Graefes Arch Clin Exp Ophthalmol; 1999 Feb; 237(2):100-4. PubMed ID: 9987624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An in-service investigation of the additive effect of topical adrenergic agonists and beta-blockers.
    Gillies WE; Brooks AM
    Aust N Z J Ophthalmol; 1998 Aug; 26(3):215-8. PubMed ID: 9717752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 24-hour control of intraocular pressure with 2% dorzolamide/0.5% timolol fixed-combination ophthalmic solution in open-angle glaucoma.
    Feldman RM; Stewart RH; Stewart WC; Jia G; Smugar SS; Galet VA
    Curr Med Res Opin; 2008 Aug; 24(8):2403-12. PubMed ID: 18627642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Betaxolol. A new beta-adrenergic blocking agent for treatment of glaucoma.
    Berrospi AR; Leibowitz HM
    Arch Ophthalmol; 1982 Jun; 100(6):943-6. PubMed ID: 6124227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary open-angle glaucoma patients characterized by ocular vasospasm demonstrate a different ocular vascular response to timolol versus betaxolol.
    Evans DW; Harris A; Cantor LB
    J Ocul Pharmacol Ther; 1999 Dec; 15(6):479-87. PubMed ID: 10609770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serial administration of adrenergic antagonist and agonist ("pulsatile therapy") reduces the incidence of long-term drift to timolol in humans.
    Gandolfi SA; Vecchi M
    Invest Ophthalmol Vis Sci; 1996 Mar; 37(4):684-8. PubMed ID: 8595970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorophotometric study of epinephrine and timolol in human subjects.
    Schenker HI; Yablonski ME; Podos SM; Linder L
    Arch Ophthalmol; 1981 Jul; 99(7):1212-6. PubMed ID: 7259595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Additive effect of epinephrine to timolol therapy in primary open angle glaucoma.
    Cyrlin MN; Thomas JV; Epstein DL
    Arch Ophthalmol; 1982 Mar; 100(3):414-8. PubMed ID: 7065957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Timolol, betaxolol and befunolol in the treatment of glaucoma. Study of their bronchopulmonary effects].
    Pecori-Giraldi J; Collini S; Planner-Terzaghi A; Arrico L; Grechi G
    Fortschr Ophthalmol; 1988; 85(3):235-8. PubMed ID: 2905321
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of dorzolamide/timolol and latanoprost/timolol fixed combinations on diurnal intraocular pressure control in primary open-angle glaucoma.
    Eren MH; Gungel H; Altan C; Pasaoglu IB; Sabanci S
    J Ocul Pharmacol Ther; 2012 Aug; 28(4):381-6. PubMed ID: 22320418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.